@TrialsCentre Thank you to everyone at the CTC, and in the broader Clinical Trials community.
Your hard work, your dedication and your commitment to excellence in research helps shape the future of healthcare and improves the lives of patients and their families around the world!
THANK YOU!
Donโt miss our next session of CTC Talks: Learning! Join us as @jardine_meg shares the innovative ways #KidneyDisease can adapt to trial design opportunities. ๐https://t.co/zLOjV2YQ8j
๐ Explore all upcoming CTC Talks: Learning events๐https://t.co/0691RMCYKi ๐บ Watch past sessions ๐ https://t.co/yZNjqgPnXr
Thats it from tonightโs discussion of #Nephtrials. Hope we can continue to increase awareness about ongoing trials in nephrology and learn about their designs and the efforts that go into conducting them #nephtrials
$$$ is a BIG challenge! Support for rare disease research in the academic environment is hard to come by. BEAT-Calci is designed to be capable of evaluating question's from academic & commercial partners. Research collaborations are needed. #Nephtrials
@jardine_meg Slightly off topic
Reading/writing the blog makes me want to enrol calxiohylaxis patients in ๐จ๐ฆ
Any plans to have North America included?
#NephTrials
Adaptive Sample Size Reestimation: Allows the study to drop treatment arms early, based on accumulating data through prespecified decision rules - for e.g. success or futility. Focusing resources where its needed! #NephTrials
Response Adaptive Randomisation: Weighting the randomisation towards the most promising treatment, based on accumulating data. Allowing us to speed up evidence generation on the most promising treatments #NephTrials
Generating evidence in a rare disease is hard work! BEAT-Calci is growing, with AUS & NZ recruiting, and the UK in early set up. Additional regions across Europe, Asia & the Americas in discussion. Truly a global effort! #NephTrials#calciphylaxis
BEAT-Calci is a global (Australia, New Zealand and UK), randomized adaptive, multi-center, platform trial that will evaluate multiple interventions across several domains of therapeutic care in calciphylaxis #nephtrials
@_ArlenWilcox@manasib33@remap_cap Thanks!
This was a nice figure to explain platform trials from https://t.co/TIlyVaYqFm
But itโs the adaptive elements that are ๐คฏ
#NephTrials
@hswapnil@manasib33@remap_cap ... & a Platform trial is a type of multi-arm study that allows for arms to be removed once sufficiently assessed, or added to the trial where new information warrants their inclusion. Some studies like BEAT-Calci are adaptive & a platform! #NephTrials
@hswapnil@manasib33@remap_cap Great thoughts Swapnil! An adaptive design is any design which uses accumulating data to decide how to modify aspects of the study without undermining the validity and integrity of the trial. #nephtrials
Looking forward to an exciting #nephtrials session! I'm Arlen Wilcox, Associate Director, Trials Development at @TrialsCentre within @Sydney_Uni
Exciting to work on the BEAT-Calci Trial using novel & innovative methodology to generate much needed evidence in #calciphylaxis
Looking forward to #nephtrials tonight to chat with BEAT-Calci team @jardine_meg@KrishRathika@_ArlenWilcox and learn more about the adaptive platform design and its complexities! join us at 9pm EST. https://t.co/XNhMgrVL44
๐ฆ๐๐ฉ๐ ๐ง๐๐ ๐๐๐ง๐ for the next #NephTrials, an ISN-
@NephJC joint discussion on "The BEAT-Calciย Trial."
๐๏ธ November 21
๐ 9 pm EST
Warm up with this great visual abstract by @divyaa24 and stay tuned for the @NephJC blog post.